MHC class I- and class II-restricted processing and presentation of microencapsulated antigens

Vaccine

Volumn 17, Issue 9-10, 1999, Pages 1047-1056

  Men, Ying ^a   Audran, Régine ^a   Thomasin, Claudio ^b   Eberl, Gérard ^a   Demotz, Stéphane ^a   Merkle, Hans Peter ^b   Gander, Bruno ^b   Corradin, Giampietro ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BREFELDIN A; CD4 ANTIGEN; CD8 ANTIGEN; CHLOROQUINE; CYCLOHEXIMIDE; CYTOCHALASIN D; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TETANUS TOXOID;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; HUMAN; HUMAN CELL; MACROPHAGE FUNCTION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MICROENCAPSULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

AMINO ACID SEQUENCE; ANIMALS; BREFELDIN A; CELL LINE; CYCLOHEXIMIDE; DRUG COMPOUNDING; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MACROPHAGES; MICE; MOLECULAR SEQUENCE DATA; PROTEIN SYNTHESIS INHIBITORS; TUMOR CELLS, CULTURED;

EID: 0033525913     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00321-1     Document Type: Article

References (59)

1. Germain R.N., Margulies D.H. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol. 11:1993;403.
2. Monaco JJ. Molecular mechanisms of antigen processing. In: Hames BD, Glover DM, editors. Molecular immunology. Oxford: IRL Press, 1996. p. 212.
3. Robadey C, Demotzs. Peptide-MHC complexes assembled following multiple pathways. In: Gander B, Merkle HP, Corradin G, editors. Antigen delivery systems. Amsterdam: Harwood, 1997. p. 15.
4. Wolf P.R., Ploegh H.L. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Ann Rev Cell Dev Biol. 11:1995;267.
5. York I.A., Rock K.L. Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol. 14:1996;369.
6. Harding C.V. Phagocytic processing of antigens for presentation by MHC molecules. Trends Cell Biology. 5:1996;105.
7. Roche P.A., Marks M.S., Cresswell P. Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain. Nature. 354:1991;392.
8. Sanderson F., Kleijmeer M.J., Kelly A., Verwoerd D., Tulp A., Neefjes J.J., Geuze H.J., Trowsdale J. Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments. Science. 266:1994;1566.
9. Sherman M.A., Weber D.A., Jensen P.E. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity. 3:1995;197.
10. Hammerling G.J., Moreno J. The function of the invariant chain in antigen presentation by MHC class II molecules. Immunol Today. 11:1990;337.
11. Viville S., Neefjes J., Lotteau V., Dierich A., Lemeur M., Ploegh H., Benoist C., Mathis D. Mice lacking the MHC class II-associated invariant chain. Cell. 72:1993;635.
12. Bikoff E.K., Huang L.Y., Episkopou V., van Meerwijk J., Germain R.N., Robertson E.J. Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression. J Exp Med. 177:1993;1699.
13. Pinet V., Malnati M.S., Long E.O. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J Immunol. 152:1994;4852.
14. Pinet V., Vergelli M., Martin R., Bakke O., Long E.O. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature. 375:1995;603.
15. Robadey C., Ammerlaan W., Muller C., Cloutier I., Sekaly R.P., Haefliger J.A., Demotz S. The processing routes determined by negatively charged residues in DR1-restricted T cell determinants. J Immunol. 159:1997;3238.
16. Matousek M.P., Nedrud J.G., Harding C.V. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages. J Immunol. 156:1996;4137.
17. Harding C.V., Geuze H.J. Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells. J Cell Biol. 119:1992;531.
18. Bevan M.J. Antigen presentation to cytotoxic T lymphocytes in vivo. J Exp Med. 182:1995;639.
19. Rock K.L. A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today. 17:1996;131.
20. Jondal M., Schirmbeck R., Reimann J. MHC class I-restricted CTL responses to exogenous antigens Immunity. 5:1996;295.
21. Takahashi H., Takeshita T., Morein B., Putney S., Germain R.N., Berzofsky J.A. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature. 344:1990;873.
22. Debrick J.E., Campbell P.A., Staerz U.D. Macrophages as accessory cells for class I MHC-restricted immune responses. J Immunol. 147:1991;2846.
23. Heeg K., Kuon W., Wagner H. Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide. Eur J Immunol. 21:1991;1523.
24. Carbone F.R., Bevan M.J. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med. 171:1990;377.
25. Huang A.Y., Golumbek P., Ahmadzadeh M., Jaffee E., Pardoll D., Levitsky H. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science. 264:1994;961.
26. Kovacsovics-Bankowski M., Clark K., Benacerraf B., Rock K.L. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Nat Acad Sci USA. 90:1993;4942.
27. Bohm W., Schirmbeck R., Elbe A., Melber K., Diminky D., Kraal G., van Rooijen N., Barenholz Y., Reimann J. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. J Immunol. 155:1995;3313.
28. Harding C.V., Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol. 153:1994;4925.
29. Blum-Tirouvanziam U., Beghdadi-Rais C., Roggero M.A., Valmori D., Bertholet S., Bron C., Fasel N., Corradin G. Elicitation of specific cytotoxic T cells by immunization with malaria soluble synthetic polypeptides. J Immunol. 153:1994;4134.
30. Men Y., Tamber H., Audran R., Gander B., Corradin G. Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide based on biodegradable polymer microspheres. Vaccine. 15:1997;1405.
31. Kovacsovics-Bankowski M., Rock K.L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science. 267:1995;243.
32. Reis e Sousa C., Germain R.N. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med. 182:1995;841.
33. De Bruijn M.L., Jackson M.R., Peterson P.A. Phagocyte-induced antigen-specific activation of unprimed CD8+ T cells in vitro. Eur J Immunol. 25:1995;1274.
34. Song R., Harding C.V. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J Immunol. 156:1996;4182.
35. Malaviya R., Twesten N.J., Ross E.A., Abraham S.N., Pfeifer J.D. Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol. 156:1996;1490.
36. Schirmbeck R., Bohm W., Melber K., Reimann J. Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation. J Immunol. 155:1995;4676.
37. Schirmbeck R., Melber K., Reimann J. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur J Immunol. 25:1995;1063.
38. Eisenlohr L.C., Bacik I., Bennink J.R., Bernstein K., Yewdell J.W. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell. 71:1992;963.
39. Kozlowski S., Corr M., Takeshita T., Boyd L.F., Pendleton C.D., Germain R.N., Berzofsky J.A., Margulies D.H. Serum angiotensin-1 converting enzyme activity processes a human immunodeficiency virus 1 gp160 peptide for presentation by major histocompatibility complex class I molecules. J Exp Med. 175:1992;1417.
40. Men Y., Thomasin C., Merkle H.P., Gander B., Corradin G. A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide. Vaccine. 13:1995;683.
41. Men Y., Gander B., Merkle H.P., Corradin G. Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres. Vaccine. 14:1996;1442.
42. Eldridge J.H., Staas J.K., Meulbroeck J.A., MacGhee J.R., Tice T.R., Gilley R.M. Biodegradable microspheres as a vaccine delivery system. Mol Immunol. 28:1991;287.
43. Singh M., Singh A., Talwar G.P. Controlled delivery of diphteria toxoid using biodegradable poly(D,L-lactide) microcapsules. Pharm Res. 8:1991;958.
44. Alonso M.J., Gupta R.K., Min C., Siber G.R., Langer R. Biodegradable microspheres as controlled release tetanus toxoid delivery system. Vaccine. 12:1994;299.
45. Jones D.H., McBride B.W., Jeffery H., O'Hagan D.T., Robinson, Farrar G.H. Protection of mice from Bordetella pertussis, respiratory infection using microencapsulated pertussis fimbriae. Vaccine. 13:1995;675.
46. Marx P.A., Compans R.W., Gettie A., Staas J.K., Gilley R.M., Mulligan M.J., Yamshchkov G.V., Chen D., Eldridge J.H. Protection against vaginal SIV transmission with microencapsulated vaccine. Science. 260:1993;1323.
47. Visscher G.E., Robison R.L., Maulding H.V., Fong J.W., Pearson J.E., Argentieri G.J. Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules. J Biomed Mater Res. 19:1985;349.
48. Visscher G.E., Robison R.L., Maulding H.V., Fong J.W., Pearson J.E., Argentieri G.J. Biodegradation of and tissue reaction to poly(DL-lactide) microcapsules. J Biomed Mater Res. 20:1986;667.
49. Allen P., Beller D., Braun J., Unanue E. The handling of Listeria monocytogenes by macrophages: the search for an immunogenic molecules in antigen presentation. J Immunol. 132:1984;323.
50. Lang T., Kaye P.M. Presentation of Leishmania donovani promastigotes occurs via a brefeldin A-sensitive pathway. Eur J Immunol. 21:1991;2407.
51. Pfeifer J.D., Wick M.J., Russell D.G., Normark S.J., Harding C.V. Recombinant Escherichia coli express a defined, cytoplasmic epitope that is efficiently processed in macrophage phagolysosomes for class II MHC presentation to T lymphocytes. J Immunol. 149:1992;2576.
52. Vidard L., Kovacsovics-Bankowski M., Kraeft S-K., Chen L.B., Benacerraf B., Rock K.L. Analysis of MHC class II presentation of particulate antigens by B lymphocytes. J Immunol. 156:1996;2809.
53. Panina-Bordignon P., Tan A., Termijtelen A., Demotz S., Corradin G., Lanzavecchia A. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur J Immunol. 19:1989;2237.
54. Maryanski J.L., Pala P., Cerottini J.C., Corradin G. Synthetic peptides as antigens and competitors in recognition by H-2-restricted cytolytic T cells specific for HLA. J Exp Med. 167:1988;1391.
55. Thomasin C., Corradin G., Men Y., Merkle H.P., Gander B. Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: importance of polymer degradation and antigen release for immune response. J Control Release. 41:1996;131.
56. Brissinck J., Demanet C., Moser M., Leo O., Thielemans K. Treatment of mice bearing BCL1 lymphoma with bispecific antibodies. J Immunol. 147:1991;4019.
57. Korn E.D. Actin polymerization and its regulation by proteins from nonmuscle cells. Physiol Rev. 62:1982;672.
58. Lowe J., Stock D., Jap B., Zwickl P., Baumeister W., Huber R. Crystal structure of the 20 S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science. 268:1995;533.
59. Mathiowitz E., Jacob J.S., Jong Y.S., Carino G.P., Chickering D.E., Chaturvedi P., Santos C.A., Vijayaraghavan K., Montgomery S., Bassett M., Morrell C. Biologically erodable microspheres as potential oral drug delivery systems. Nature. 386:1997;410.